Author: xiaofengxia01
-
Emerging Drug Trends in the U.S.: Why Real-Time Detection Is Becoming Essential
Emerging Drug Trends in the U.S.: Why Real-Time Detection Is Becoming Essential The composition of the illicit drug supply in the United States has changed significantly over the past decade, with increasing complexity and variability creating new challenges for healthcare providers and community organizations. According to the Centers for Disease Control and Prevention (CDC), synthetic… Read more
-
A Breakthrough in Xylazine Detection: High-Sensitivity Rapid Dipstick Developed by Instanosis
The opioid crisis continues to evolve with new challenges, and xylazine, an animal tranquilizer increasingly found in illicit drug supplies, has emerged as a dangerous adulterant linked to severe wounds, sedation, and rising overdose deaths. Detecting this compound rapidly and reliably in clinical settings has been a significant unmet need. Our founders, Dr. Ping Wang… Read more
-
Instanosis Wins Prestigious Award for Breakthrough Xylazine Detection Technology
Instanosis Wins Prestigious Award for Breakthrough Xylazine Detection Technology Chicago, IL – July 23, 2025 — Instanosis, a diagnostics company advancing ultra-sensitive drug testing technologies, has been named a recipient of the Academy of Diagnostics & Laboratory Medicine’s Distinguished Abstract Award at the upcoming ADLM 2025 Annual Meeting. The award honors the scientific excellence of… Read more
-
Why Ultra-Sensitive Drug Detection Matters at the Point of Care
The opioid crisis continues to evolve, with increasingly potent and unpredictable substances fueling a rise in overdose deaths across the U.S. In this high-stakes environment, healthcare professionals, harm reduction teams, and first responders face pressure to detect and respond to synthetic opioids and novel adulterants with speed, precision, and confidence. Yet many of today’s testing… Read more